Nektar Therapeutics (NASDAQ:NKTR)
| 4.00 Delayed Data As of Jun 24 |  -0.16 / -3.85%Today’s Change | 3.02 Today|||52-Week Range 19.37 | -70.39% Year-to-Date |
Latest NKTR News | Press Releases
No recent news for Nektar Therapeutics.
Today’s Trading
| Previous close | 4.16 |
| Today’s open | 4.21 |
| Day’s range | 3.98 - 4.26 |
| Volume | 781,625 |
| Average volume (3 months) | 3,908,458 |
| Market cap | $745.1M |
Data as of 5:17pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | -14.83% |
| Earnings growth (this year) | +19.25% |
| Earnings growth (next 5 years) | +8.74% |
| Revenue growth (last year) | -33.36% |
| P/E ratio | NM |
| Price/Sales | 24.30 |
| Price/Book | 1.09 |
Competitors
| ---- | ||
| SRNESorrento Therapeutic... | -0.21 | -9.43% |
| COGTCogent Biosciences I... | -0.47 | -4.83% |
| ATRAAtara Biotherapeutic... | -0.04 | -0.54% |
Data as of 4:01pm ET, 06/24/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.94 |
| Annual revenue (last year) | $101.9M |
| Annual profit (last year) | -$523.8M |
| Net profit margin | -514.03% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
